Indefinite Delivery Contract SPE2DP26D0001
- Not listed
- This indefinite delivery contract, awarded by the Defense Logistics Agency Troop Support Medical, provides for the delivery of various medical products and treatments to the U.S. government. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract, valued at up to $597 million, has a period of performance from January 1, 2013 to December 31, 2014. It does not utilize any set-aside designations. Meridian has been awarded multiple delivery...
- Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., was awarded the MANDRAKE 3.0 Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the Department of State Bureau of Medical Services on September 30, 2023, with a five-year performance period through September 29, 2025, and a ceiling value of $100 million. This single-award contract, which requires no small business set-aside designation, authorizes the delivery of autoinjectors and associated training devices...
- The Department of Defense's Joint Program Executive Office for Chemical and Biological Defense awarded an Other Transaction Indefinite Delivery Vehicle valued at approximately $1.0 million to Meridian Medical Technologies, LLC on June 3, 2024. This OT IDV, which carries no small business set-aside designation, is structured to facilitate product enhancements designed to improve the reliability of Antidote Treatment Nerve Agent Autoinjector (ATNAA) devices. As a wholly-owned subsidiary of...
- This Indefinite Delivery Contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to the prime contractor Pfizer Inc., a large pharmaceutical manufacturer. The contract has a ceiling value of $48,683,160.88 and a period of performance through August 31, 2030. It does not utilize any small business set-asides. The contract primarily aims to procure a wide range of pharmaceutical products and medical supplies for the Department of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Pfizer Inc. to supply a wide range of pharmaceutical products, including prescription medications, vaccines, and other critical medical supplies to support various government healthcare initiatives. The $10 million IDC has an ultimate completion date of December 18, 2024 and was originally procured through a competitive solicitation that sought proposals to establish multiple...
- This single-award Indefinite Delivery Contract, valued at $9.55 million with an ultimate completion date of August 25, 2027, was awarded by the Defense Logistics Agency's Medical Supply Chain division to Mylan Pharmaceuticals Inc. on August 26, 2022. The contract encompasses the manufacture and distribution of pharmaceutical products classified under the Federal Supply Classification code 4610093699. As the prime contractor, Mylan Pharmaceuticals Inc. (UEI: NDN1MYB8DKK5), a registered for-profit...
- Mylan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency (Defense sector) with a ceiling value of $10.97 million on September 14, 2022. The contract classification identifies the awardee as a manufacturer/distributor for pharmaceutical products and is scheduled for ultimate completion on September 13, 2027. No small business set-aside was utilized in this award. The contract represents a continuation of Mylan's existing relationship...
- The Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The 11-year contract (base period plus options) will serve as a prime vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 single award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC, which runs through December 2036, serves as a primary vehicle for procuring specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $9,999,999.00, runs through December 31, 2025 and serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
Meridian Medical Technologies, LLC, a Pfizer subsidiary based in St. Louis, Missouri, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with a ceiling value of $226.44 million and an ultimate completion date of December 4, 2028. The contract contains no small business set-aside designation and procures medical countermeasures and emergency medical equipment, specifically autoinjector devices and nerve agent antidote treatments. As a wholly-owned subsidiary of Pfizer with federal contractor registration dating to January 2002, Meridian serves as a critical supplier to multiple federal agencies responsible for national preparedness and chemical-biological defense, with primary product offerings including DuoDote autoinjectors containing atropine and pralidoxime chloride for nerve agent exposure treatment. The contractor's established expertise in autoinjector manufacturing and medical countermeasures positions it strategically within the federal procurement landscape for emergency medical response capabilities. The contract reflects Meridian's ongoing role as a key supplier of medical countermeasures to federal agencies including the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Department of State Bureau of Medical Services, the U.S. Marshals Service Tactical Operations Division, and the Department of Defense Joint Program Executive Office for Chemical and Biological Defense. Recent significant awards to Meridian include a $129.7 million firm-fixed-price contract from HHS ASPR in September 2024 for DuoDote autoinjectors for the Strategic National Stockpile and multiple delivery orders under the Department of State's MANDRAKE 3.0 Indefinite Delivery, Indefinite Quantity contract totaling approximately $21.4 million. This Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract represents continued federal investment in reliable, domestically-manufactured nerve agent antidote treatment capabilities supporting military and civilian defense personnel across strategic stockpiling and emergency response missions through December 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/4/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Antidote Treatment Nerve Agent Auto-Injector (ATNAA) | SPE2DP-23-R-0002 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/3 | 6/6/23, 3:21 PM | |
Antidote Treatment Nerve Agent Auto-Injector (ATNAA) | SPE2DP-26-D-0001 | Defense Logistics Agency Troop Support Medical | Limited / Sole Source Justification 3/3 | 12/10/25, 9:09 AM | |
Antidote Treatment Nerve Agent Auto-Injector (ATNAA) | SPE2DP-23-R-0002 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 2/3 | 3/20/24, 7:52 AM |